Question 1

What is Atara Biotherapeutics?

Accepted Answer

Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases.

Question 2

What is the company's technology?

Accepted Answer

Atara is developing a pipeline of investigational T-cell therapies that target difficult-to-treat cancers and autoimmune conditions. Their therapies can be rapidly delivered to patients from inventory, and they are the first company to receive an approval for an allogeneic T-cell immunotherapy.

Question 3

What is the company's approach?

Accepted Answer

Atara is harnessing the natural biology of T cells, the body's most effective weapon in fighting disease, to develop transformative therapies. Their allogeneic T-cell therapies can be readily available for rapid delivery within days, and their scalable manufacturing process can produce over a thousand doses from one healthy donor.

Question 4

How does Atara's approach differ from traditional therapies?

Accepted Answer

Atara's allogeneic T-cell therapies are an "off-the-shelf" approach, meaning they can be readily available for rapid delivery to patients, unlike autologous therapies that require each patient's own cells to be collected, modified, and then re-infused. This scalable and efficient manufacturing process allows Atara to potentially treat a wider range of patients.

Voyager DB

Contact Research

People Search

Chrome Extension

Integrations

Atara Biotherapeutics

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

Established

Google Reviews

About Atara Biotherapeutics

Business Profile

About the website

Biotech & Life Sciences Companies near Thousand Oaks, CA

Frequently Asked Questions about Atara Biotherapeutics

What is Atara Biotherapeutics?

What is the company's technology?

What is the company's approach?

How does Atara's approach differ from traditional therapies?

Categories

Technologies Used

Social Profiles

Key Decision Makers